Troy Frazer, DO
Family Medicine · Niantic, CTNPI 1689775918
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,145 of the $18,325 with a category attached, or 99.0%. CSL Plasma Inc. accounts for 99.0% of it on its own, with 5 other manufacturers making up the rest. 2023 is the largest year on record at $18,145, more than ten times the $34 reported in 2020. Among family medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $1308.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$18K
- Boehringer Ingelheim$92
- AstraZeneca$36
- E.r. Squibb & Sons, L.L.C.$19
- Gilead$18
- Johnson & Johnson$16
What the payments were for
- Consulting fees$18,14599%
- Food & beverage$1801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Plasma Inc. | 6 | $18,145 |
| Boehringer Ingelheim | 3 | $92 |
| AstraZeneca | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Gilead | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
How this compares
$18,325 in reported general payments places this provider in the 95th percentile of 588 family medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 41 | $20,491 |
| Metoprolol Succinate | 34 | $258 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $186 |
| Amlodipine Besylate | 37 | $113 |
| Doxycycline Hyclate | 17 | $67 |
| Prednisone | 24 | $64 |
| Lisinopril | 14 | $20 |
| Furosemide | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Niantic
- Theodore BrunoDurham$201K
- Kenneth DardickStorrs$146K
- Raymond KurkerSouth Windsor$107K
- Thao DoranMarlborough$102K
- Raja FattalehPutnam$53K
- Nicholas TzikasNew Haven$46K
- Helar CamposNew London$29K
- Kristin GianniniVernon$28K
- Sanjeev RaoBridgeport$27K
- Michael BeyVernon Rockville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.